181 related articles for article (PubMed ID: 38414029)
1. E-cadherin variants associated with oral facial clefts trigger aberrant cell motility in a REG1A-dependent manner.
Pereira J; Melo S; Ferreira RM; Carneiro P; Yang V; Maia AF; Carvalho J; Figueiredo C; Machado JC; Morais-de-Sá E; Seruca R; Figueiredo J
Cell Commun Signal; 2024 Feb; 22(1):152. PubMed ID: 38414029
[TBL] [Abstract][Full Text] [Related]
2. CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract][Full Text] [Related]
3. The ECM and tissue architecture are major determinants of early invasion mediated by E-cadherin dysfunction.
Melo S; Guerrero P; Moreira Soares M; Bordin JR; Carneiro F; Carneiro P; Dias MB; Carvalho J; Figueiredo J; Seruca R; Travasso RDM
Commun Biol; 2023 Nov; 6(1):1132. PubMed ID: 37938268
[TBL] [Abstract][Full Text] [Related]
4. Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells.
Figueiredo J; Ferreira RM; Xu H; Gonçalves M; Barros-Carvalho A; Cravo J; Maia AF; Carneiro P; Figueiredo C; Smith ML; Stamenović D; Morais-de-Sá E; Seruca R
Gastric Cancer; 2022 Jan; 25(1):124-137. PubMed ID: 34486077
[TBL] [Abstract][Full Text] [Related]
5. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.
Simões-Correia J; Figueiredo J; Lopes R; Stricher F; Oliveira C; Serrano L; Seruca R
PLoS One; 2012; 7(3):e33783. PubMed ID: 22470475
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
8. Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts.
Vogelaar IP; Figueiredo J; van Rooij IA; Simões-Correia J; van der Post RS; Melo S; Seruca R; Carels CE; Ligtenberg MJ; Hoogerbrugge N
Hum Mol Genet; 2013 Mar; 22(5):919-26. PubMed ID: 23197654
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
10. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications.
Lim HJ; Zhuang L; Fitzgerald RC
J Exp Clin Cancer Res; 2023 Mar; 42(1):57. PubMed ID: 36869400
[TBL] [Abstract][Full Text] [Related]
11. The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC.
Figueiredo J; Söderberg O; Simões-Correia J; Grannas K; Suriano G; Seruca R
Eur J Hum Genet; 2013 Mar; 21(3):301-9. PubMed ID: 22850631
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia.
Pereira PS; Teixeira A; Pinho S; Ferreira P; Fernandes J; Oliveira C; Seruca R; Suriano G; Casares F
Hum Mol Genet; 2006 May; 15(10):1704-12. PubMed ID: 16600987
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin mutations and cell motility: a genotype-phenotype correlation.
Mateus AR; Simões-Correia J; Figueiredo J; Heindl S; Alves CC; Suriano G; Luber B; Seruca R
Exp Cell Res; 2009 May; 315(8):1393-402. PubMed ID: 19268661
[TBL] [Abstract][Full Text] [Related]
14. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.
Melo S; Figueiredo J; Fernandes MS; Gonçalves M; Morais-de-Sá E; Sanches JM; Seruca R
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29231860
[TBL] [Abstract][Full Text] [Related]
15. DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo.
Simões-Correia J; Silva DI; Melo S; Figueiredo J; Caldeira J; Pinto MT; Girão H; Pereira P; Seruca R
Hum Mol Genet; 2014 Apr; 23(8):2094-105. PubMed ID: 24293545
[TBL] [Abstract][Full Text] [Related]
16. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
17. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
18. Hereditary diffuse gastric cancer (HDGC). An overview.
Taja-Chayeb L; Vidal-Millán S; Trejo-Becerril C; Pérez-Cárdenas E; Chávez-Blanco A; Domínguez-Gómez G; González-Fierro A; Romo-Pérez A; Dueñas-González A
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101820. PubMed ID: 34656755
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
20. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
